.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Acquired EGFR-TKI resistance remains a significant challenge in managing non-small cell lung cancer (NSCLC), even with advanced therapies like osimertinib. While genomic mutations often drive this resistance, recent studies highlight the critical role of the tumor immune microenvironment. Specifically, researchers have identified that RNA methylation regulated by NSUN2 significantly impacts how cancer cells evade the immune system.
Recent experiments using gefitinib- and osimertinib-resistant NSCLC models revealed a startling contrast. Under immunodeficient conditions, knocking down NSUN2 had no impact on tumor growth. However, in immunocompetent environments, NSUN2 deficiency suppressed tumor proliferation and restored drug sensitivity. This suggests that the resistance is not just intrinsic to the cell but is heavily mediated by immune evasion. By removing NSUN2, 'cold' resistant tumors effectively transform into 'hot' tumors that the immune system can recognize and attack.
Mechanistically, the loss of NSUN2 promotes macrophage migration and enhances M0-to-M1 polarization. M1 macrophages are known for their anti-tumor activity, whereas M2 macrophages typically support tumor growth. Therefore, reversing this polarization helps combat EGFR-TKI resistance. The study pinpointed the E3 ubiquitin ligase TRIM29 as a critical target in this process. When NSUN2 is deficient, TRIM29 levels drop, leading to the beneficial shift in macrophage behavior and increased tumor infiltration.
These findings position NSUN2 as a primary driver of acquired EGFR-TKI resistance through epigenetic regulation. By targeting the NSUN2-TRIM29 axis, clinicians might eventually be able to reprogram the immune microenvironment. This approach could potentially extend the efficacy of EGFR inhibitors and provide new hope for patients who have exhausted standard treatment options. Furthermore, understanding these 'hot' and 'cold' tumor dynamics is essential for the future of personalized oncology in India and globally.
NSUN2 is an enzyme responsible for RNA methylation. In NSCLC, it acts as a driver of immune evasion, helping tumor cells stay hidden from the immune system and contributing to drug resistance.
'Cold' tumors have little immune cell infiltration, making them resistant to many treatments. Converting them to 'hot' tumors means increasing the presence of active immune cells, like M1 macrophages, which helps the body and drugs fight the cancer.
Yes. Identifying NSUN2 and TRIM29 as regulators of immune response opens the door for developing new drugs that could be used alongside current EGFR inhibitors to prevent or reverse resistance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Wang Y et al. Tumor cell-intrinsic NSUN2 deficiency reprograms macrophages to sensitize non-small cell lung cancer to EGFR inhibitors by reversing immune evasion. Neoplasia. 2026 Jun 12. doi: undefined. PMID: 42284680.
Yang Y, et al. NSUN2/ALYREF axis-driven m(5)C methylation enhances PD-L1 expression and facilitates immune evasion in non-small-cell lung cancer. Nat Commun. 2024;15(1):1234.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research identifies NSUN2 deficiency as a key factor in reversing immune evasion and overcoming EGFR-TKI resistance in NSCLC by reprogramming macrophage polarization. This epigenetic shift converts 'cold' tumors into 'hot' tumors, offering a promising target for advanced lung cancer therapy.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
